Kaempferol inhibits osteoclast differentiation and bone resorption by targeting the TNF-α/NF-κB and SRC/PI3K/AKT

Qiting Yu1, Taiping Jiang2, Yunpeng Zhao1

  • 1Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, 550000, China.

Scientific Reports
|January 27, 2026
PubMed

Insights

Kaempferol effectively inhibits osteoclast differentiation and bone resorption by targeting key signaling pathways, offering a potential therapeutic strategy for osteoporosis. This study elucidates its dual action against osteoclastogenesis and oxidative stress.

Area of Science:

  • Pharmacology and Traditional Chinese Medicine
  • Molecular Biology and Biochemistry
  • Bone Biology and Osteoporosis Research

Background:

  • Osteoporosis is a significant skeletal disorder characterized by decreased bone mass and increased fracture risk.
  • Kaempferol, a natural flavonoid, shows promise in regulating osteoporosis, but its precise molecular mechanisms require detailed investigation.
  • Understanding kaempferol's targets and pathways is crucial for developing novel anti-osteoporotic therapies.

Purpose of the Study:

  • To elucidate the molecular mechanism of kaempferol's anti-osteoporotic effects using network pharmacology and experimental validation.
  • To identify key targets and signaling pathways modulated by kaempferol in the context of osteoporosis.
  • To evaluate the inhibitory effects of kaempferol on osteoclast differentiation and oxidative stress.

Main Methods:

  • Network pharmacology approach utilizing TCMSP and SwissTargetPrediction databases to identify kaempferol targets.
  • Protein-protein interaction (PPI) network analysis, Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment.
  • Experimental validation in RAW 264.7 cells, including cell viability assays, osteoclast differentiation and resorption assessments, oxidative stress marker analysis, and molecular mechanism studies (RT-qPCR, Western blotting).

Main Results:

  • Network pharmacology identified 37 core targets and highlighted kaempferol's high binding affinity with AKT, NF-κB, PI3K, SRC, and TNF-α.
  • Kaempferol significantly increased RAW 264.7 cell viability, dose-dependently inhibited osteoclast differentiation and bone resorption, and reduced oxidative stress markers (ROS, MDA) while increasing SOD activity.
  • Kaempferol downregulated osteoclastogenesis-related genes (RANK, CSF1R, c-Fos, CTSK, MMP-9) and inhibited the TNF-α/NF-κB and SRC/PI3K/AKT signaling pathways.

Conclusions:

  • Kaempferol demonstrates dual inhibitory effects on osteoclast differentiation and oxidative stress, validating its anti-osteoporotic potential.
  • The anti-resorptive activity of kaempferol is attributed to the coordinated inhibition of RANK/M-CSF signaling and downstream TNF-α/NF-κB and SRC/PI3K/AKT pathways.
  • These findings provide a comprehensive understanding of kaempferol's molecular mechanisms, supporting its development as a therapeutic agent for osteoporosis.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.5K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.0K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.1K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.5K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
10.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.3K